diabetes

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Long MannKind's Afrezza: Shares Versus A Bull Call Spread

Seeking Alpha

Submitted by admin on Wed, 11/28/2012 - 00:27

Medtronic, Dexcom and Abbott Offer New Products to a Growing Diabetic Population in Europe, a €5 Billion + Market

Medtronic, Dexcom and Abbott Offer New Products to a Growing Diabetic Population in Europe, a €5 Billion + Market

equities.com

Novo Nordisk says new data show Victoza advantage

Novo Nordisk says new data show Victoza advantage

Reuters

Novo Nordisk A/S: Catching The Increasing Diabetes Trend

Novo Nordisk A/S: Catching The Increasing Diabetes Trend

Seeking Alpha

Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer

Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer

Bloomberg

Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer

Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer

Bloomberg

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster

AstraZeneca's Forxiga For Type 2 Diabetes Is A Potential Blockbuster

Seeking Alpha

Biocon, Bristol-Myers in deal for oral insulin drug

Biocon, Bristol-Myers in deal for oral insulin drug

Reuters

Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union

Bristol-Myers, AstraZeneca Type 2 diabetes pill gets first major approval, in European Union

Yahoo/AP

Who Will Pioneer the New Diabetes Market?

Who Will Pioneer the New Diabetes Market?

Motley Fool